Literature DB >> 2914154

Circadian rhythms of melatonin and cortisol in aging.

M Sharma1, J Palacios-Bois, G Schwartz, H Iskandar, M Thakur, R Quirion, N P Nair.   

Abstract

The relationship of age to the circadian rhythms of melatonin and cortisol was investigated in 44 men and 27 women (age range 19-89 years). Subjects were physically and psychiatrically normal. Four hourly serial blood samples were drawn from 8:00 AM until 8:00 AM the next day, with additional samples at 10:00 PM and 2:00 AM. The indoor illumination was restricted to 300 lux during day and 50 lux during the night. Plasma melatonin and cortisol were estimated by radioimmunoassay. Results show that the means of melatonin and cortisol values decreased significantly with age when the subjects were divided into three age groups, i.e., 19-25 years, 42-65 years, and 66-89 years. They also showed a significant negative correlation with age. The acrophases of the two hormonal rhythms, however, showed different relationships to age. The acrophase of melatonin rhythm showed a positive correlation with age (r = 0.38, p less than 0.001), and cortisol showed a negative correlation with age (r = -0.56, p greater than 0.001). It is suggested that this may indicate a weakened responsiveness of the circadian system in the elderly to the day-night cycle and an altered relationship between the pacemakers driving melatonin and cortisol circadian rhythms. This may thus represent a biomarker for the intrinsic process of the aging of the brain.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2914154     DOI: 10.1016/0006-3223(89)90178-9

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  49 in total

1.  Seasonal pattern of melatonin excretion in humans: relationship to daylength variation rate and geomagnetic field fluctuations.

Authors:  T J Paparrigopoulos; C N Stefanis
Journal:  Experientia       Date:  1996-03-15

2.  Impact of an Individually Tailored Light Mask on Sleep Parameters in Older Adults With Advanced Phase Sleep Disorder.

Authors:  Mariana G Figueiro; Philip D Sloane; Kimberly Ward; David Reed; Sheryl Zimmerman; John S Preisser; Seema Garg; Christopher J Wretman
Journal:  Behav Sleep Med       Date:  2018-12-27       Impact factor: 2.964

Review 3.  Circadian rhythm sleep disorders: pathophysiology and potential approaches to management.

Authors:  N Zisapel
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

4.  Potential of melatonin replacement therapy in older patients with sleep disorders.

Authors:  I Haimov; P Lavie
Journal:  Drugs Aging       Date:  1995-08       Impact factor: 3.923

5.  Pineal control of aging: effect of melatonin and pineal grafting on aging mice.

Authors:  W Pierpaoli; W Regelson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

Review 6.  Mechanisms of age-related endocrine alterations. Part II.

Authors:  A D Mooradian
Journal:  Drugs Aging       Date:  1993 Mar-Apr       Impact factor: 3.923

7.  Circadian rhythm of glucose utilization in the pineal body of rats of different ages.

Authors:  R Cicciarello; M E Gagliardi; F Albiero; M Mesiti; A d'Aquino; E Ciriaco; G Germanà; E Cardia; D d'Avella
Journal:  Childs Nerv Syst       Date:  1993-02       Impact factor: 1.475

8.  Alterations in glutamatergic signaling contribute to the decline of circadian photoentrainment in aged mice.

Authors:  Stephany M Biello; David R Bonsall; Lynsey A Atkinson; Penny C Molyneux; Mary E Harrington; Gurprit S Lall
Journal:  Neurobiol Aging       Date:  2018-02-20       Impact factor: 4.673

9.  Psychological correlates of salivary cortisol secretion among unemployed men and women.

Authors:  G Grossi; A Ahs; U Lundberg
Journal:  Integr Physiol Behav Sci       Date:  1998 Jul-Sep

Review 10.  Age-dependent and gender-dependent regulation of hypothalamic-adrenocorticotropic-adrenal axis.

Authors:  Johannes D Veldhuis; Animesh Sharma; Ferdinand Roelfsema
Journal:  Endocrinol Metab Clin North Am       Date:  2013-03-13       Impact factor: 4.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.